Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Scientific Reports|September 21, 2019
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancerGarazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, et al.
The Breast Journal|April 12, 2011
Combined modality therapy of stage IIIC breast cancerRodrigo Dienstmann, Luís Guilherme Branco, Lígia M Rezende, et al.
Targeted Oncology|August 28, 2015
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid TumorsRodrigo Dienstmann, Ulrik Lassen, Jonathan Cebon, et al.
Journal of Market Access & Health Policy|November 10, 2022
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence ScenarioFlavia A Duarte, Carlos Gil Ferreira, Rodrigo Dienstmann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2023
Clinical and genomic characterisation of early-onset pancreatic cancerFlorian Castet, Carles Fabregat-Franco, Gloria Castillo, et al.
Urologic Oncology|June 17, 2008
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapyMarcos B Pinho, Fernanda Costas, João Sellos, et al.
Clinical Lung Cancer|February 22, 2007
Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancerRenato G Martins, Rodrigo Dienstmann, Paulo de Biasi, et al.
Communications Medicine|May 3, 2024
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancerDaan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, et al.
Nature Communications|March 25, 2026
TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matchingMajd Abdallah, Sigve Nakken, Mikaël Georges, et al.
JTO Clinical and Research Reports|February 27, 2026
Adjuvant Larotrectinib in a Resected Secretory Carcinoma-Like Lung Adenocarcinoma Harboring EML4-NTRK3 Fusion: Case ReportVladmir Cláudio Cordeiro de Lima, Breno Jeha Araújo, Felipe D' Almeida Costa, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Scientific Reports|September 21, 2019
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancerGarazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, et al.
The Breast Journal|April 12, 2011
Combined modality therapy of stage IIIC breast cancerRodrigo Dienstmann, Luís Guilherme Branco, Lígia M Rezende, et al.
Targeted Oncology|August 28, 2015
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid TumorsRodrigo Dienstmann, Ulrik Lassen, Jonathan Cebon, et al.
Journal of Market Access & Health Policy|November 10, 2022
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence ScenarioFlavia A Duarte, Carlos Gil Ferreira, Rodrigo Dienstmann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2023
Clinical and genomic characterisation of early-onset pancreatic cancerFlorian Castet, Carles Fabregat-Franco, Gloria Castillo, et al.
Urologic Oncology|June 17, 2008
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapyMarcos B Pinho, Fernanda Costas, João Sellos, et al.
Clinical Lung Cancer|February 22, 2007
Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancerRenato G Martins, Rodrigo Dienstmann, Paulo de Biasi, et al.
Communications Medicine|May 3, 2024
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancerDaan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, et al.
Nature Communications|March 25, 2026
TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matchingMajd Abdallah, Sigve Nakken, Mikaël Georges, et al.
JTO Clinical and Research Reports|February 27, 2026
Adjuvant Larotrectinib in a Resected Secretory Carcinoma-Like Lung Adenocarcinoma Harboring EML4-NTRK3 Fusion: Case ReportVladmir Cláudio Cordeiro de Lima, Breno Jeha Araújo, Felipe D' Almeida Costa, et al.
Pageof 18